SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QIAGEN (QGENF) - Star of Germany's Biotechs

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: (no name provided) who wrote (16)3/8/1997 8:18:00 AM
From: Zeitgeist   of 122
 
I am confused too,

I participated in the run first, but I lost my nerves and
sold at 32. Thereafter, I wanted to short but etrade had
no stocks available to borrow.

As it was discussed a month ago or so, the reasonable trading-
range of this stock should be between 15-20.

IMO, there is no way that qgenf will continue to climb.
Maybe we are seeing a short squeeze right now.

Another thing that bothers me is the big spread between
bid and ask price. It is really hard to daytrade this stock
with this spreads.

I'll try to short again on Monday -
or is there any news we don't know ?
Did they found a way to prevent licence payments for
PCR to La Roche or so ...

Maybe the people expect more revenues from qiagens step
towards the PCR technology. However, this market is dominated
by Perkin Elmer. Qiagen has no name in this field (yet).

S
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext